{"id":358,"date":"2026-06-04T16:45:30","date_gmt":"2026-06-04T08:45:30","guid":{"rendered":"https:\/\/okdental.cn\/?p=358"},"modified":"2026-08-04T15:38:17","modified_gmt":"2026-08-04T07:38:17","slug":"ahk-innovation-night","status":"publish","type":"post","link":"https:\/\/okdental.cn\/vi\/ahk-innovation-night\/","title":{"rendered":"C\u00f4ng ty C\u00f4ng ngh\u1ec7 Sinh h\u1ecdc Jingyin t\u1ecfa s\u00e1ng t\u1ea1i \u0110\u00eam S\u00e1ng t\u1ea1o AHK: C\u00f4ng ngh\u1ec7 t\u00e1i t\u1ea1o x\u01b0\u01a1ng \u0111\u1ed9t ph\u00e1 thu h\u00fat s\u1ef1 ch\u00fa \u00fd to\u00e0n c\u1ea7u"},"content":{"rendered":"
\n\t\t\t\t
\n
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Suzhou, China \u2013 July 2026<\/strong>\u00a0\u2013 Jiaxing Jingyin Biotechnology Co., Ltd., the parent company of Beijing OKVD Biological Technology Co., Ltd., made a powerful debut on the internatioal stage at the 2026 AHK Innovation Night<\/strong>, hosted by the German Chamber of Commerce (AHK Greater China)<\/strong>. This high-profile event brought together nearly 40 elite tech startups from across China, along with top-tier investors, industry experts, and overseas chambers of commerce, to foster cross-border innovation and commercial collaboration in healthcare.<\/p>

After rigorous multi-round selection, Jingyin Biotechnology emerged as one of only eight finalists, standing out with its proprietary hard tissue regeneration technology\u2014Infibond<\/strong>. The company\u2019s performance earned widespread acclaim from global delegates, marking a significant milestone in its journey toward becoming a world-class biomedical materials innovator.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

A Compelling Story: \u201cThe Silent War Inside Us\u201d<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

During the pitch session, Jingyin Biotechnology delivered a captivating presentation titled \u201cThe Silent War Inside Us.\u201d<\/strong>\u00a0Using an analogy of a collapsing city calling for emergency rescue, the team vividly illustrated the long-standing clinical pain points of traditional bone cement\u2014a market with over 30 million procedures performed globally each year.<\/p>

The presentation highlighted critical shortcomings of conventional products:<\/p>

Exothermic peak temperature<\/strong>can reach up to 100\u00b0C during curing, causing thermal necrosis of surrounding tissues.<\/p>

Residual monomer content<\/strong>as high as 3.54%, posing moderate biotoxicity and increasing risks of inflammation, embolism, and severe implantation syndrome.<\/p>

Clinical mortality rate<\/strong>of 0.6%\u20131%, imposing heavy burdens on patients and families.<\/p>

These challenges have persisted for decades, underscoring the urgent need for disruptive innovation\u2014and Jingyin Biotechnology has delivered exactly that.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Infibond: Three Breakthrough Advantages<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Jingyin Biotechnology\u2019s independently developed Infibond bone cement achieves a comprehensive technological leap with three core advantages:<\/p>

Safe Temperature Control<\/strong>\u2013 The curing temperature is precisely regulated between 35\u00b0C and 40\u00b0C<\/strong>, matching human physiological levels and eliminating the risk of thermal injury.<\/p>

Superior Biosafety<\/strong>\u2013 Through optimized material formulation, residual monomer content has been reduced from 3.54% to just 38%<\/strong>, drastically lowering toxicity. Cell attachment rate reaches 99%<\/strong>, demonstrating biocompatibility far exceeding traditional imported products.<\/p>

World-First Bone Regeneration<\/strong>\u2013 By incorporating a unique hydrophilic microsphere structure, Infibond slowly releases space for new bone cell growth after implantation. This allows the material to integrate seamlessly with native bone tissue, achieving true \u201crepair + regeneration\u201d<\/strong>\u00a0\u2014a paradigm shift from conventional bone cement which only fills defects without promoting regrowth.<\/p>

Animal experiment data presented at the event confirmed that both first-generation and second-generation Infibond effectively induce new bone formation, validating its regenerative capability.<\/p>

This original technology has already secured invention patents in China, the United States, and Japan<\/strong>. Moreover, it was selected for the 2025 Ministry of Industry and Information Technology (MIIT) & National Medical Products Administration (NMPA) \u201cOpen Competition\u201d program<\/strong>\u00a0for biomedical materials\u2014the only project in China\u2019s hard tissue bonding field to receive this national-level endorsement.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Expanding Applications Beyond Orthopedics<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Infibond is not limited to orthopedics. Its versatile applications span multiple disciplines:<\/p>

Orthopedics<\/strong>: Spinal repair, joint replacement, and other core procedures, tapping into a multi-billion-dollar bone cement market.<\/p>

Dentistry & Neurosurgery<\/strong>: Leveraging 3D printing bionic technology to develop novel implant systems and PEEK cranial repair solutions, revolutionizing traditional treatment approaches.<\/p>

Frontier Technology<\/strong>: In partnership with Sigenics (USA)<\/strong>, a world-leading brain-computer interface chip team, Jingyin Biotechnology is contributing to the \u201cMoon Shot\u201d BCI project. The material\u2019s exceptional sealing properties and biocompatibility solve the critical challenge of long-term micro-leakage in implanted chips, laying a safety foundation for next-generation medical devices.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<\/div>\n
\n
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

A Milestone Toward Global Leadership<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u201cThis is a pivotal moment for Jingyin Biotechnology,\u201d said Xiu Cai, the International Marketing Manager.\u00a0\u201cWe are committed to continuous innovation in biomedical materials, leveraging our proprietary core technologies to bring \u2018Created in China\u2019 high-end medical solutions to the world. With our growing global partner network, we aim to lead the transformation of regenerative medicine.\u201d<\/p>

As the parent company of Beijing OKVD Biological Technology Co., Ltd.<\/strong>\u00a0, Jingyin Biotechnology\u2019s breakthrough reinforces the combined strength of the Jingyin & OKVD group\u2014offering a complete range of dental and orthopedic consumables backed by world-class R&D.<\/p>

S\u1ef1 ch\u00ednh x\u00e1c v\u00f4 t\u1eadn, s\u1ef1 ch\u0103m s\u00f3c v\u01b0\u1ee3t th\u1eddi gian.<\/strong>\u00a0The future of bone regeneration has arrived.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t<\/div>","protected":false},"excerpt":{"rendered":"

T\u00f4 Ch\u00e2u, Trung Qu\u1ed1c \u2013 Th\u00e1ng 7 n\u0103m 2026 \u2013 C\u00f4ng ty TNHH C\u00f4ng ngh\u1ec7 Sinh h\u1ecdc Jiaxing Jingyin, c\u00f4ng ty m\u1eb9 c\u1ee7a C\u00f4ng ty TNHH C\u00f4ng ngh\u1ec7 Sinh h\u1ecdc B\u1eafc Kinh OKVD,<\/p>","protected":false},"author":1,"featured_media":1218,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-358","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/posts\/358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/comments?post=358"}],"version-history":[{"count":21,"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/posts\/358\/revisions"}],"predecessor-version":[{"id":1553,"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/posts\/358\/revisions\/1553"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/media\/1218"}],"wp:attachment":[{"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/media?parent=358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/categories?post=358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/okdental.cn\/vi\/wp-json\/wp\/v2\/tags?post=358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}